A 14C ORAL BIOAVAILIBITY MICROTRACER STUDY SHOWS THAT ORAL ACETAMINOPHEN EXPOSURE IS LOW AND ERRATIC IN CRITICALLY ILL CHILDREN: A CASE FOR IV ACETAMINOPHEN.

N. Kleiber, E. Calvier, M. G. Mooij, E. H. Krekels, W. H. Vaes, A. D. Windhorst, H. Hendrikse, D. Tibboel, C. A. Knibbe, S. N. de Wildt

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S41-S41
JournalClinical Pharmacology & Therapeutics
Volume103
Publication statusPublished - Mar 2018

Cite this